Activity, assay and target data curation and quality in the ChEMBL database

Journal of Computer-Aided Molecular Design

Volumn 29, Issue 9, 2015, Pages 885-896

  Papadatos, George ^a   Gaulton, Anna ^a   Hersey, Anne ^a   Overington, John P ^a  

^a EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Italy)

Author keywords

Data curation; Data quality; Public bioactivity databases

Indexed keywords

BIOASSAY;

'CURRENT; ACTIVITY ASSAYS; DATA ACCESSIBILITY; DATA COMPARABILITIES; DATA CURATION; DATA INTEGRITY; DATA QUALITY; PUBCHEM; PUBLIC BIOACTIVITY DATABASE;

DATABASE SYSTEMS;

ACCESS TO INFORMATION; ACCURACY; AMBIGUITY; ARTICLE; AUTHOR; BIOASSAY; CALCULATION; CHEMBL DATABASE; CHEMICAL DATABASE; DATA EXTRACTION; EXPERIMENTATION; INFORMATION RETRIEVAL; PRIORITY JOURNAL; PUBLICATION; QUALITY CONTROL; STANDARDIZATION; SYSTEMATIC ERROR; WORKFLOW; FACTUAL DATABASE; IC50; INFORMATION PROCESSING; MEASUREMENT ACCURACY; STANDARDS;

BIOLOGICAL ASSAY; DATA ACCURACY; DATA CURATION; DATABASES, CHEMICAL; DATABASES, FACTUAL; INHIBITORY CONCENTRATION 50;

EID: 84944353181     PISSN: 0920654X     EISSN: 15734951     Source Type: Journal    
DOI: 10.1007/s10822-015-9860-5     Document Type: Article

References (45)

1. Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP (2012) ChEMBL: a large-scale bioactivity database for drug discovery. Nucleic Acids Res 40(D1):D1100-D1107. doi: 10.1093/nar/gkr777
2. Bento AP, Gaulton A, Hersey A, Bellis LJ, Chambers J, Davies M, Krüger FA, Light Y, Mak L, McGlinchey S, Nowotka M, Papadatos G, Santos R, Overington JP (2014) The ChEMBL bioactivity database: an update. Nucleic Acids Res 42(D1):D1083-D1090. doi: 10.1093/nar/gkt1031
3. Papadatos G, Overington JP (2014) The ChEMBL database: a taster for medicinal chemists. Future Med Chem 6(4):361-364
4. Wang Y, Xiao J, Suzek TO, Zhang J, Wang J, Zhou Z, Han L, Karapetyan K, Dracheva S, Shoemaker BA, Bolton E, Gindulyte A, Bryant SH (2012) PubChem's BioAssay database. Nucleic Acids Res 40(D1):D400-D412. doi: 10.1093/nar/gkr1132
5. Liu T, Lin Y, Wen X, Jorrisen RN, Gilson MK (2007) BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinities. Nucleic Acids Res 35:D198-D201
6. Pawson AJ, Sharman JL, Benson HE, Faccenda E, Alexander SP, Buneman OP, Davenport AP, McGrath JC, Peters JA, Southan C, Spedding M, Yu W, Harmar AJ, NC-IUPHAR (2014) The IUPHAR/BPS guide to pharmacology: an expert-driven knowledgebase of drug targets and their ligands. Nucleic Acids Res 42(D1):D1098-D1106
7. Law V, Knox C, Djoumbou Y, Jewison T, Guo AC, Liu Y, Maciejewski A, Arndt D, Wilson M, Neveu V, Tang A, Gabriel G, Ly C, Adamjee S, Dame ZT, Han B, Zhou Y, Wishart DS (2014) DrugBank 4.0: shedding new light on drug metabolism. Nucleic Acids Res 42(D1):D1091-D1097
8. Besnard J, Ruda GF, Setola V, Abecassis K, Rodriguiz RM, Huang X-P, Norval S, Sassano MF, Shin AI, Webster LA, Simeons FRC, Stojanovski L, Prat A, Seidah NG, Constam DB, Bickerton GR, Read KD, Wetsel WC, Gilbert IH, Roth BL, Hopkins AL (2012) Automated design of ligands to polypharmacological profiles. Nature 492 (7428):215-220. http://www.nature.com/nature/journal/v492/n7428/abs/nature11691.html
9. Lounkine E, Keiser MJ, Whitebread S, Mikhailov D, Hamon J, Jenkins JL, Lavan P, Weber E, Doak AK, Cote S, Shoichet BK, Urban L (2012) Large-scale prediction and testing of drug activity on side-effect targets. Nature 486 (7403):361-367. http://www.nature.com/nature/journal/v486/n7403/abs/nature11159.html
10. Martínez-Jiménez F, Papadatos G, Yang L, Wallace IM, Kumar V, Pieper U, Sali A, Brown JR, Overington JP, Marti-Renom MA (2013) Target prediction for an open access set of compounds active against Mycobacterium tuberculosis. PLoS Comput Biol 9(10):e1003253. doi: 10.1371/journal.pcbi.1003253
11. Wirth M, Zoete V, Michielin O, Sauer WHB (2013) SwissBioisostere: a database of molecular replacements for ligand design. Nucleic Acids Res 41(D1):D1137-D1143. doi: 10.1093/nar/gks1059
12. Hu Y, Bajorath J (2012) Extending the activity cliff concept: structural categorization of activity cliffs and systematic identification of different types of cliffs in the ChEMBL database. J Chem Inf Model 52(7):1806-1811
13. Kim Kjærulff S, Wich L, Kringelum J, Jacobsen UP, Kouskoumvekaki I, Audouze K, Lund O, Brunak S, Oprea TI, Taboureau O (2013) ChemProt-2.0: visual navigation in a disease chemical biology database. Nucleic Acids Res 41(D1):D464-D469
14. Southan C, Varkonyi P, Boppana K, Jagarlapudi SA, Muresan S (2013) Tracking 20 years of compound-to-target output from literature and patents. PLoS One 8(10):e77142
15. Hersey A, Senger S, Overington JP (2012) Open data for drug discovery: learning from the biological community. Future Med Chem 4(15):1865-1867. doi: 10.4155/fmc.12.159
16. Williams AJ, Harland L, Groth P, Pettifer S, Chichester C, Willighagen EL, Evelo CT, Blomberg N, Ecker G, Goble C, Mons B (2012) Open PHACTS: semantic interoperability for drug discovery. Drug Discov Today 17(21-22):1188-1198. doi: 10.1016/j.drudis.2012.05.016
17. Spangenberg T, Burrows JN, Kowalczyk P, McDonald S, Wells TN, Willis P (2013) The open access malaria box: a drug discovery catalyst for neglected diseases. PLoS One 8(6):e62906
18. Gamo FJ, Sanz LM, Vidal J, de Cozar C, Alvarez E, Lavandera JL, Vanderwall DE, Green DV, Kumar V, Hasan S, Brown JR, Peishoff CE, Cardon LR, Garcia-Bustos JF (2010) Thousands of chemical starting points for antimalarial lead identification. Nature 465(7296):305-310
19. Southan C, Sitzmann M, Muresan S (2013) Comparing the Chemical Structure and Protein Content of ChEMBL, DrugBank, Human Metabolome Database and the Therapeutic Target Database. Mol Inform 32(11-12):881-897
20. Williams AJ, Ekins S (2011) A quality alert and call for improved curation of public chemistry databases. Drug Discov Today 16(17-18):747-750. doi: 10.1016/j.drudis.2011.07.007
21. Fourches D, Muratov E, Tropsha A (2010) Trust, but verify: on the importance of chemical structure curation in cheminformatics and QSAR modeling research. J Chem Inf Model 50(7):1189-1204. doi: 10.1021/ci100176x
22. Tiikkainen P, Bellis L, Light Y, Franke L (2013) Estimating error rates in bioactivity databases. J Chem Inf Model 53(10):2499-2505. doi: 10.1021/ci400099q
23. Kramer C, Kalliokoski T, Gedeck P, Vulpetti A (2012) The experimental uncertainty of heterogeneous public Ki data. J Med Chem 55(11):5165-5173. doi: 10.1021/jm300131x
24. Kalliokoski T, Kramer C, Vulpetti A (2013) Quality issues with public domain chemogenomics data. Mol Inform 32(11-12):898-905. doi: 10.1002/minf.201300051
25. Yu M, Selvaraj SK, Liang-Chu MM, Aghajani S, Busse M, Yuan J, Lee G, Peale F, Klijn C, Bourgon R, Kaminker JS, Neve RM (2015) A resource for cell line authentication, annotation and quality control. Nature 520(7547):307-311
26. Kramer C, Lewis R (2012) QSARs, data and error in the modern age of drug discovery. Curr Top Med Chem 12(17):1896-1902
27. Kalliokoski T, Kramer C, Vulpetti A, Gedeck P (2013) Comparability of mixed IC50 data - a statistical analysis. PLoS One 8(4):e61007. doi: 10.1371/journal.pone.0061007
28. Hersey A, Chambers J, Bellis L, Patrícia Bento A, Gaulton A, Overington JP Chemical databases: curation or integration by user-defined equivalence?. Drug Discov Today Technol (0). doi: 10.1016/j.ddtec.2015.01.005
29. Zdrazil B, Pinto M, Vasanthanathan P, Williams AJ, Balderud LZ, Engkvist O, Chichester C, Hersey A, Overington JP, Ecker GF (2012) Annotating human P-Glycoprotein bioassay data. Mol Inform 31(8):599-609
30. Visser U, Abeyruwan S, Vempati U, Smith RP, Lemmon V, Schurer SC (2011) BioAssay ontology (BAO): a semantic description of bioassays and high-throughput screening results. BMC Bioinform 12:257. doi: 10.1186/1471-2105-12-257
31. Abeyruwan S, Vempati U, Kucuk-McGinty H, Visser U, Koleti A, Mir A, Sakurai K, Chung C, Bittker J, Clemons P, Brudz S, Siripala A, Morales A, Romacker M, Twomey D, Bureeva S, Lemmon V, Schurer S (2014) Evolving BioAssay Ontology (BAO): modularization, integration and applications. J Biomed Semant 5(Suppl 1):S5
32. Gkoutos GV, Schofield PN, Hoehndorf R (2012) The units ontology: a tool for integrating units of measurement in science. Database 2012:bas033. doi: 10.1093/database/bas033
33. Hodgson R, Keller PJ, Hodges J, Spivak J (2014) QUDT - Quantities, Units, Dimensions and Data Types ontology. http://www.qudt.org
34. Santos MA, Marques S, Vullo D, Innocenti A, Scozzafava A, Supuran CT (2007) Carbonic anhydrase inhibitors: inhibition of cytosolic/tumor-associated isoforms I, II, and IX with iminodiacetic carboxylates/hydroxamates also incorporating benzenesulfonamide moieties. Bioorg Med Chem Lett 17(6):1538-1543. doi: 10.1016/j.bmcl.2006.12.107
35. Smaine F-Z, Winum J-Y, Montero J-L, Regainia Z, Vullo D, Scozzafava A, Supuran CT (2007) Carbonic anhydrase inhibitors: selective inhibition of the extracellular, tumor-associated isoforms IX and XII over isozymes I and II with glycosyl-thioureido-sulfonamides. Bioorg Med Chem Lett 17(18):5096-5100. doi: 10.1016/j.bmcl.2007.07.019
36. Koutsoukas A, Lowe R, Kalantarmotamedi Y, Mussa HY, Klaffke W, Mitchell JB, Glen RC, Bender A (2013) In silico target predictions: defining a benchmarking data set and comparison of performance of the multiclass Naïve Bayes and Parzen-Rosenblatt window. J Chem Inf Model 53(8):1957-1966
37. Gfeller D, Grosdidier A, Wirth M, Daina A, Michielin O, Zoete V (2014) SwissTargetPrediction: a web server for target prediction of bioactive small molecules. Nucleic Acids Research 42(Web Server issue):W32-W38
38. Malone J, Holloway E, Adamusiak T, Kapushesky M, Zheng J, Kolesnikov N, Zhukova A, Brazma A, Parkinson H (2010) Modeling sample variables with an experimental factor ontology. Bioinformatics 26(8):1112-1118. doi: 10.1093/bioinformatics/btq099
39. Sarntivijai S, Xiang Z, Meehan TF, Diehl AD, Vempati U, Pang C, Malone J, Parkinson HE, Athey BD (2011) Cell line ontology: redesigning the cell line knowledgebase to aid integrative translational informatics. Proc Int Conf Biomed Ontol (ICBO) 25-32
40. Mungall CJ, Torniai C, Gkoutos GV, Lewis SE, Haendel MA (2012) Uberon, an integrative multi-species anatomy ontology. Genome Biol 13:R5
41. Orchard S, Al-Lazikani B, Bryant S, Clark D, Calder E, Dix I, Engkvist O, Forster M, Gaulton A, Gilson M, Glen R, Grigorov M, Hammond-Kosack K, Harland L, Hopkins A, Larminie C, Lynch N, Mann RK, Murray-Rust P, Lo Piparo E, Southan C, Steinbeck C, Wishart D, Hermjakob H, Overington J, Thornton J (2011) Minimum information about a bioactive entity (MIABE). Nat Rev Drug Discov 10 (9):661-669. http://www.nature.com/nrd/journal/v10/n9/suppinfo/nrd3503-S1.html
42. UniProt Consortium (2015) UniProt: a hub for protein information. Nucleic Acids Res 43:D204-D212. doi: 10.1093/nar/gku989
43. Giraldo E, Vigano MA, Hammer R, Ladinsky H (1988) Characterization of muscarinic receptors in guinea pig ileum longitudinal smooth muscle. Mol Pharmacol 33(6):617-625
44. Ehlert FJ, Thomas EA (1995) Functional role of M2 muscarinic receptors in the guinea pig ileum. Life Sci 56(11-12):965-971
45. Wisden W, Laurie DJ, Monyer H, Seeburg PH (1992) The distribution of 13 GABAA receptor subunit mRNAs in the rat brain. I. Telencephalon, diencephalon, mesencephalon. J Neurosci 12(3):1040-1062